Technical Articles

Protein ligand
靶向BCL-XL的VHL依赖性PROTAC降解剂：克服血小板毒性的创新策略与试剂盒开发
VHL-dependent PROTAC degraders targeting BCL-XL: Innovative strategies to overcome platelet toxicity and development of reagent kits
发布时间 2026-01-05
BCL-XL is highly expressed in various tumor cells, promoting their survival and drug resistance.
View details
  • Cancer
  • VAV1/CRBN PROTAC Kit
  • Platelet toxicity
  • Protein ligand
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.